ZNF148 and glioma: The transcription factor ZNF148 promotes the malignant transformation of dendritic cells after cross‐talk with glioma stem cells by upregulating PTX3, and reduce the expression of co‐stimulatory factors on the surface of DCs, inhibit their antigen presentation and activation of T cells.